OBJECTIVE: The purpose of this study was to examine whether women who were treated with 17 alpha-hydroxyprogesterone caproate (17-OHPC) to prevent recurrent preterm birth experienced a change in cervical shortening over time, compared with women who were not treated. STUDY DESIGN: We conducted a retrospective exposure cohort study of women who were enrolled in a prematurity prevention clinic from 1999-2008 with a singleton pregnancy with > or =1 previous spontaneous preterm births (<37 weeks of gestation) who underwent > or =2 cervical length measurements by endovaginal ultrasound. RESULTS: Of 200 women, 105 women received treatment with 17-OHPC; 95 women did not. Women who were treated with 17-OHPC were more likely to have experienced a previous preterm birth (26.0 vs 27.8 weeks; P = .01) than those who were not treated with 17-OHPC. There was no difference in the average weekly change in cervical length among women treated with 17-OHPC, compared with those who were not, after adjustment for covariates (0.79 mm/week; 95% confidence interval, -1.18 to 2.76). CONCLUSION: There was no difference in the average weekly change in cervical length measurements over time in women who underwent 17-OHPC treatment, compared with those who were not treated.
OBJECTIVE: The purpose of this study was to examine whether women who were treated with 17 alpha-hydroxyprogesterone caproate (17-OHPC) to prevent recurrent preterm birth experienced a change in cervical shortening over time, compared with women who were not treated. STUDY DESIGN: We conducted a retrospective exposure cohort study of women who were enrolled in a prematurity prevention clinic from 1999-2008 with a singleton pregnancy with > or =1 previous spontaneous preterm births (<37 weeks of gestation) who underwent > or =2 cervical length measurements by endovaginal ultrasound. RESULTS: Of 200 women, 105 women received treatment with 17-OHPC; 95 women did not. Women who were treated with 17-OHPC were more likely to have experienced a previous preterm birth (26.0 vs 27.8 weeks; P = .01) than those who were not treated with 17-OHPC. There was no difference in the average weekly change in cervical length among women treated with 17-OHPC, compared with those who were not, after adjustment for covariates (0.79 mm/week; 95% confidence interval, -1.18 to 2.76). CONCLUSION: There was no difference in the average weekly change in cervical length measurements over time in women who underwent 17-OHPC treatment, compared with those who were not treated.
Authors: E R Guzman; C Walters; C V Ananth; C O'Reilly-Green; C W Benito; A Palermo; A M Vintzileos Journal: Ultrasound Obstet Gynecol Date: 2001-09 Impact factor: 7.299
Authors: J Owen; N Yost; V Berghella; E Thom; M Swain; G A Dildy; M Miodovnik; O Langer; B Sibai; D McNellis Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: B M Mercer; R L Goldenberg; A H Moawad; P J Meis; J D Iams; A F Das; S N Caritis; M Miodovnik; M K Menard; G R Thurnau; M P Dombrowski; J M Roberts; D McNellis Journal: Am J Obstet Gynecol Date: 1999-11 Impact factor: 8.661
Authors: Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Fay Menacker; Melissa M Park; Paul D Sutton Journal: Natl Vital Stat Rep Date: 2002-12-18
Authors: Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe Journal: N Engl J Med Date: 2003-06-12 Impact factor: 91.245
Authors: Ruben J Kuon; Shao-Qing Shi; Holger Maul; Christof Sohn; James Balducci; William L Maner; Robert E Garfield Journal: Am J Obstet Gynecol Date: 2010-05 Impact factor: 8.661
Authors: Vincenzo Berghella; Dana Figueroa; Jeff M Szychowski; John Owen; Gary D V Hankins; Jay D Iams; Jeanne S Sheffield; Annette Perez-Delboy; Deborah A Wing; Edwin R Guzman Journal: Am J Obstet Gynecol Date: 2010-04 Impact factor: 8.661
Authors: Steve N Caritis; Raman Venkataramanan; Elizabeth Thom; Margaret Harper; Mark A Klebanoff; Yoram Sorokin; John M Thorp; Michael W Varner; Ronald J Wapner; Jay D Iams; Marshall W Carpenter; William A Grobman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan Ramin Journal: Am J Obstet Gynecol Date: 2013-10-07 Impact factor: 8.661
Authors: Michael A Kirby; Anne C Heuerman; Melisa Custer; Abigail E Dobyns; Ryan Strilaeff; Kathleen N Stutz; Jaclyn Cooperrider; Joseph G Elsissy; Steven M Yellon Journal: Reprod Sci Date: 2016-05-27 Impact factor: 3.060